TITAN PHARMACEUTICALS INC — Director's Dealing 2015

Oct 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2015-09-30

Reporting Person: BHONSLE SUNIL (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-30	Common Stock	P	500	$3.98	Acquired	90774	Direct
2015-10-01	Common Stock	P	200	$3.99	Acquired	90974	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54684	Indirect

Footnotes

F1: The reporting person serves as trustee of the family trust.